Ill-I I I I. . ?Built(:47 NDRAMCO 

EFFIEET ELITE EM 
m-EF'E-tm? FIJI 3131-5133420

Cum-huh 15, EWE

MEI. Ed 

tilt: nf Supply Hm?mmt
PF Lat-mamas

Uniun Buulu'ard

Tatum-Ia, New Just}; MS [1

Dear Ed;

We in: plusutl h: tum-king with PF Murat-cm: at: that supply tut" Th:
qua??'lng maltrlIl 50m titre: hatches tan ht: sent this mun-nth.

w: 1111:: nut: signi?cant. mam:- ttnu: mu matting of July 29. FitsL we have united
the high Enchant: CPS hum Tasmanian mutt-ids, mpl?td [ht llbuI-Emrjr and att-
5mm,w:haue de?dndtu
1:11. ante that whadule t'trt implemmtatinn of twu ut' [hi threa- changts WE:
discusind' 1n Jul J?ghue The third Francis Ellinl? [Phase is m. the lab- and with:
EJH. quarter 1999 as m: In. July.

That: ?putty tmntimt 111: i151: still an innit. First. the fittiity to pruduu
lit: and ?nal step: hazy-mum will but ml?n? by warren Sit-mud. It:
mginn?ng fur ufnu: hy?ngem?hn. ?putty is well Third. the
{acuity in Atlas will bl.? mmpletnd by yam-end. Th: stun up schadula will dnpeud an
tlmtan?. Finally. w: at: beginning moth. tut gutting um DEA li??m?i Athms.

Th. pmpl: gh'l thgethitr My mdersunding hf I11: mgulat?-?' situatinn

15-:

We had 111: twi??un that initial qualil'tnatiun wuuld he: differcnt frat-n a E?l'm?l
SHEA.

2] Th: putts: will he by Hartman mu.- BACPAC uguiatium. FF
will 1:11:11 I5- Than.- mnuld mt tn: any dif?nutty-

3} Altjmugh ll was ml: dimmd. nu: titan-tenant: is that qu?l?ca?nn Inf Amt-.115 tar. ha:
Hated as LCBE.

I 511mm aha m?m that w: wart just 1:35pm by the DA in Winning-an and
received three my minut- 433 cums-115. The recent FDA. inspectitm in Athens ranked
in m: 43} Th: Techninl will he in um year
at which. the new facility we at: dimming Will be showcastd.

 



mm

 

"'Ems?h?tua

P301 701549792
- SUBJECT PRDTECTNE ORDER

IH EGMMUHWEALTH E1 REL. JACK GENERAL It. FUREHJE 
EML ESTIDH HID. DI- EDS GIFEGLFIT 

50494-00111

 

 

Thebainc
As discussed in my letter of August 10, in the context of a long-term agreement,
Noramco will work with PF Laboratories to secure its cnt'ge, worldwide requirements.

This is not a minor point As we have discussed, access to raw materials is going to be
critical to obtaining security of supply.

Engine
We have been discussing of oxy'codone for many years now- The proposal we
have made above involves commitments such as

I Accelerating bringing capacity on stream
- Dedicating capacity to PP Laboratories? requirements
- Changing Tasmanian Alkaloitls? cultivation 2' extraction strategy

With a long term commitment, Noramco can work to provide even more capacin than in

this proposal that will give PF Laboratories the maxirnum securityr of supply for its
franchise by virtue of:

a) having two sources of supply both with proven compliance track records and both
with state?of-thc-art facilities,

b) gaining access to raw materials on a worldwide basis which simply,F cannot be
provided by any other company.

Of course, we need long term commitment from PF Laboratories to be able to provide the

support this proposal envisions-

Shicircly, 


Michael B. Kind an